Title : Activation of AKT1/GSK-3β/β-Catenin-TRIM11/Survivin Pathway by Novel GSK-3β Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model.

Pub. Date : 2016 Dec

PMID : 26660108






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The objective of this study is to elucidate the effect of a new glycogen synthase kinase-3beta (GSK-3beta) inhibitor in RA differentiated SH-SY5Y cells in oxygen and glucose deprivation (OGD) model. Oxygen glycogen synthase kinase 3 beta Homo sapiens
2 The objective of this study is to elucidate the effect of a new glycogen synthase kinase-3beta (GSK-3beta) inhibitor in RA differentiated SH-SY5Y cells in oxygen and glucose deprivation (OGD) model. Oxygen glycogen synthase kinase 3 beta Homo sapiens